NCT00361634View on ClinicalTrials.gov

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

March 31, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etanercept

Trial Locations (3)

Unknown

Research Site, Los Angeles

Research Site, Seattle

Research Site, London

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00361634 - Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter